• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Rho GTPase-activating protein 20 (ARHGAP20), Truncated

ACP10510

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10510 Target NameARHGAP20
Target SynonymsARHGAP20; KIAA1391; Rho GTPase-activating protein 20; Rho-type GTPase-activating protein 20FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9P2F6
Background Information
  • Uniprot Id

    Q9P2F6

  • Target Species

    Human

  • Target Name

    ARHGAP20

  • Target Full Name

    Rho GTPase-activating protein 20

  • Target Function

    GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.

  • Target Involvement

    A chromosomal aberration involving ARHGAP20 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL) (PubMed:15543602). Translocation t(X;11)(q21;q23) with BRWD3 does not result in fusion transcripts but disrupts both genes (PubMed:15543602).

  • Target Tissue Specificity

    Expressed predominantly in the brain. Lower expression is found in lymph nodes.

  • Target Synonyms

    ARHGAP20; KIAA1391; Rho GTPase-activating protein 20; Rho-type GTPase-activating protein 20

Inquire Recombinant Human Rho GTPase-activating protein 20 (ARHGAP20), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification